SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-22-060153
Filing Date
2022-03-01
Accepted
2022-03-01 09:40:35
Documents
8
Effectiveness Date
2022-03-01

Document Format Files

Seq Description Document Type Size
1 POSASR d657964dposasr.htm POSASR 359445
2 EX-5.1 d657964dex51.htm EX-5.1 30516
3 EX-23.2 d657964dex232.htm EX-23.2 1903
4 EX-FILING FEES d657964dexfilingfees.htm EX-FILING FEES 19640
5 GRAPHIC g657964dsp1.jpg GRAPHIC 2982
6 GRAPHIC g657964dsp2-6.jpg GRAPHIC 2253
7 GRAPHIC g657964g04a00.jpg GRAPHIC 36552
8 GRAPHIC g657964g34a58.jpg GRAPHIC 40879
  Complete submission text file 0001193125-22-060153.txt   518423
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-244401 | Film No.: 22694572
SIC: 2834 Pharmaceutical Preparations